![Russell Clayton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Russell Clayton
Technik-/Wissenschafts-/F&E-Leiter bei
LARIMAR THERAPEUTICS, INC.
Vermögen: 248 622 $ am 31.05.2026
Profil
Russell G.
Clayton is currently Chief Medical Officer at Larimar Therapeutics, Inc. since 2023.
Former positions include Regional Medical Director-Scientific Affairs at Merck & Co., Inc., Director-Asthma Program Division at The Children's Hospital of Philadelphia Foundation, Chief Medical Officer at Alcresta Therapeutics, Inc. from 2015 to 2017, and Senior Vice President-Research & Development at Windtree Therapeutics, Inc. from 2011 to 2014.
Education includes undergraduate studies at LaSalle University and a doctorate from Philadelphia College of Osteopathic Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.01.2026 | 71.443 ( 0,08 % ) | 248 622 $ | 31.05.2026 |
Aktive Positionen von Russell Clayton
| Unternehmen | Position | Beginn |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 17.07.2023 |
Ehemalige bekannte Positionen von Russell Clayton
| Unternehmen | Position | Ende |
|---|---|---|
Alcresta Therapeutics, Inc.
 Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops enzyme-based products that deliver enzymatic solutions to those living with rare diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2017 |
| WINDTREE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2014 |
The Children's Hospital of Philadelphia Foundation
 The Children's Hospital of Philadelphia Foundation Hospital/Nursing ManagementHealth Services Provides health care services | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Russell Clayton
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
26
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Windtree Therapeutics, Inc.
 Windtree Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics to address significant unmet medical needs in acute care markets | Health Technology |
LaSalle University
 LaSalle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Children's Hospital of Philadelphia Foundation
The Children's Hospital of Philadelphia Foundation Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Philadelphia College of Osteopathic Medicine
 Philadelphia College of Osteopathic Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops enzyme-based products that deliver enzymatic solutions to those living with rare diseases | Health Technology |
Larimar Therapeutics, Inc.
 Larimar Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing treatments for complex rare diseases | Health Technology |
